R-Ketamine Hydrochloride Injection(Jiangsu Hansoh)

盐酸(R)-氯胺酮注射剂（ 江苏豪森）

Report date: 2026/03/04 20:01:44

Base Information

Drug NameR-Ketamine Hydrochloride Injection(Jiangsu Hansoh)
Drug Alias NameR-氯胺酮盐酸盐盐酸(R)-氯胺酮盐酸R-氯胺酮盐酸（R）-氯胺酮注射液HS-10519 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Hansoh Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Hansoh Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A